Biogen Idec gains commercial rights of Tysabri from Elan Corporation
Biogen Idec has completed its purchase of Elan Corporation’s interest in Tysabri (natalizumab) and has gained full strategic, commercial and decision-making rights of Tysabri. The transaction was originally announced on February 6, 2013....................Read More - http://www.ms-uk.org/index.cfm/tysabri
Biogen Idec gains commercial rights of Tysabri from Elan
Biogen Idec gains commercial rights of Tysabri from Elan
MS-UK - http://www.ms-uk.org/
- HarryZ
- Family Elder
- Posts: 2572
- Joined: Tue May 25, 2004 2:00 pm
- Location: London, ON, Canada
- Contact:
Re: Biogen Idec gains commercial rights of Tysabri from Elan
Makes you wonder if Elan knows something about Tysabri that we don't and got out after making as much money as they could.squiffy2 wrote:Biogen Idec gains commercial rights of Tysabri from Elan Corporation
Biogen Idec has completed its purchase of Elan Corporation’s interest in Tysabri (natalizumab) and has gained full strategic, commercial and decision-making rights of Tysabri. The transaction was originally announced on February 6, 2013....................Read More - http://www.ms-uk.org/index.cfm/tysabri
-
- Similar Topics
- Replies
- Views
- Last post